2-201258707-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001080125.2(CASP8):​c.151+325C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.574 in 151,986 control chromosomes in the GnomAD database, including 26,078 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 26078 hom., cov: 31)

Consequence

CASP8
NM_001080125.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.710

Publications

38 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001080125.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001080125.2
c.151+325C>T
intron
N/ANP_001073594.1
CASP8
NM_001400642.1
c.151+325C>T
intron
N/ANP_001387571.1
CASP8
NM_001228.5
c.-26-7754C>T
intron
N/ANP_001219.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000358485.8
TSL:1
c.151+325C>T
intron
N/AENSP00000351273.4
CASP8
ENST00000264275.9
TSL:1
c.-26-7754C>T
intron
N/AENSP00000264275.5
CASP8
ENST00000392258.7
TSL:1
c.-26-7754C>T
intron
N/AENSP00000376087.3

Frequencies

GnomAD3 genomes
AF:
0.574
AC:
87209
AN:
151868
Hom.:
26080
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.417
Gnomad AMI
AF:
0.743
Gnomad AMR
AF:
0.501
Gnomad ASJ
AF:
0.540
Gnomad EAS
AF:
0.699
Gnomad SAS
AF:
0.630
Gnomad FIN
AF:
0.611
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.667
Gnomad OTH
AF:
0.558
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.574
AC:
87224
AN:
151986
Hom.:
26078
Cov.:
31
AF XY:
0.571
AC XY:
42411
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.417
AC:
17279
AN:
41448
American (AMR)
AF:
0.500
AC:
7643
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1873
AN:
3470
East Asian (EAS)
AF:
0.698
AC:
3607
AN:
5164
South Asian (SAS)
AF:
0.632
AC:
3043
AN:
4814
European-Finnish (FIN)
AF:
0.611
AC:
6440
AN:
10542
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.667
AC:
45315
AN:
67960
Other (OTH)
AF:
0.555
AC:
1168
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1783
3566
5349
7132
8915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
744
1488
2232
2976
3720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.642
Hom.:
53384
Bravo
AF:
0.560
Asia WGS
AF:
0.641
AC:
2229
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.63
DANN
Benign
0.88
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3769821; hg19: chr2-202123430; API